Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic

por Hernández-Jiménez, Sergio, García-Ulloa, Ana Cristina, Alcántara-Garcés, María Teresa, Urbina-Arronte, Luz Elena, Lara-Sánchez, Carolina, Velázquez-Jurado, Héctor Rafael
Publicado 2021

Use of PCSK9 Inhibitor in a Mexican Boy with Compound Heterozygous Familial Hypercholesterolemia: A Case Report

por Ceballos-Macías, José Juan, Madriz-Prado, Ramón, Vázquez Cárdenas, Norma Alejandra, Aguilar-Salinas, Carlos, Tusié-Luna, Maria Teresa, Flores-Real, Jorge Alberto, Ortega-Gutiérrez, Guillermo, Vargas-Sánchez, Joel, Lara-Sánchez, Carolina, Hernández-Moreno, Alfredo
Publicado 2019

PCSK-9 Inhibitors in a Real-World Setting and a Comparison Between Alirocumab and Evolocumab in Heterozygous FH Patients

por Ceballos-Macías, José Juan, Lara-Sánchez, Carolina, Flores-Real, Jorge, Aguilar-Salinas, Carlos Alberto, Ortega-Gutiérrez, Guillermo, Vargas-Sánchez, Joel, Madriz-Prado, Ramón, Derosa, Giuseppe, Rodríguez-Benítez, Hazel, Baltazar-Romero, Ricardo, Lopez-Mezquita, Dante José
Publicado 2020